GSK vs SKWD · P/E 13, $103.31B cap vs P/E 19, rev $1.42B
GlaxoSmithKline PLC ADR (GSK) versus Skyward Specialty Insurance Group, Inc. Common Stock (SKWD) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Skyward Specialty Insurance Group, Inc. Common Stock (SKWD) is a insurance - property & casualty company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported SKWD revenue for 2025-12-31 was $1.42B. Net income was $170.0M. Revenue was up 23.2% from 2024-12-31 to 2025-12-31. SKWD currently screens at market cap $2.26B and trailing P/E 18.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SKWD currently screens at market cap $2.26B and trailing P/E 18.8.
Not investment advice. Open the GSK and SKWD stock pages for the full models.
Not investment advice.